.svg){kind=small}
Nov-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In Connecticut, Affinity Grow has demonstrated notable performance in the cannabis market, particularly within the Concentrates and Flower categories. In November 2025, they achieved a significant milestone by ranking 3rd in Concentrates, marking their first appearance in the top 30 for this category. This indicates a strong upward trajectory and growing consumer preference for their concentrate products. However, in the Flower category, while they maintained a strong presence, there was a slight dip from a consistent 4th place in August and September to 6th place in November. This could suggest increased competition or shifting consumer preferences within the state.
For other product categories, Affinity Grow's performance presents a mixed picture. In the Edible category, they maintained a steady 14th place ranking from August to November, except for October when they were not in the top 30, which might reflect a temporary dip in sales or inventory issues. The Pre-Roll category saw some volatility, with Affinity Grow dropping out of the top 30 in October but rebounding to 11th place in November. This fluctuation could point to seasonal trends or strategic changes in their product offerings. Meanwhile, the Vapor Pens category showed a downward trend, with rankings slipping from 6th place in September to 8th in both October and November, possibly indicating a need for innovation or marketing adjustments to regain momentum.
Competitive Landscape
In the competitive landscape of the Flower category in Connecticut, Affinity Grow has experienced notable fluctuations in its ranking and sales performance. Starting in August 2025, Affinity Grow held the 5th position, but improved to 4th place in September and October, before slipping to 6th in November. This shift indicates a dynamic market where Affinity Grow is vying for position among strong competitors. Notably, CTPharma consistently maintained a top-tier position, although it dropped from 2nd to 4th place by November, suggesting potential vulnerability. Meanwhile, Brix Cannabis (CT) saw a decline from 4th to 7th place over the same period, highlighting a downward trend that Affinity Grow could capitalize on. Despite the competitive pressure, Affinity Grow's sales remained relatively stable, with a peak in October, which could be leveraged to regain or improve its ranking in the coming months.
```
Notable Products
In November 2025, Capy (3.5g) retained its position as the top-performing product for Affinity Grow, with sales reaching 3452 units. Capy Smalls (3.5g) emerged as a strong contender, securing the second rank, despite no prior ranking in previous months. Big Ray - Capy Pre-Roll (1g) made its debut in the rankings at third place, indicating a successful introduction to the market. Sunshine Daydream (3.5g) dropped to fourth place from its previous third-place ranking in October, showing a decline in sales momentum. Ghost Train Haze (3.5g) entered the rankings at fifth place, highlighting a growing interest in this product category.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
